ARIA
Library/hormonal/HGH Fragment 176-191

HGH Fragment 176-191

Not FDA Approved⛔ WADA Banned

AOD-9604 Analog

hormonalEmergingGH Lipolytic Fragment

Modified HGH fragment (residues 176-191) with enhanced lipolytic activity. Promotes fat metabolism without affecting glucose or IGF-1. Stimulates lipolysis and inhibits lipogenesis.

Confidence
55%
Half-Life 2-3 hours
Cost ~$95/mo
Quick Reference
RouteSC injection
MechanismActivates beta-3 adrenergic receptors on adipocytes. Inhibits lipoprotein lipase...
Mol. Weight1815.97 Da
Reviewed2026-07-15

Mechanism of Action

Activates beta-3 adrenergic receptors on adipocytes. Inhibits lipoprotein lipase. No GH receptor binding — no effect on IGF-1 or glucose. Upregulates fat oxidation enzymes.

Dosing Protocol

300-500 mcg SC daily on empty stomach. 12 weeks on, 4 off.

Key Studies

2004

AOD9604 for obesity treatment

PMID 15292477clinical_trial
2015

Fat loss peptides review

PMID 25670234review

Adverse Effects

Contraindications

    Storage

    2-8°C. Protect from light. Use within 30 days.

    Clinical Applications

    • Targeted fat loss
    • obesity management
    • body composition
    • metabolic syndrome